25.06.2014
- Merck Serono, the biopharmaceutical division of Germany's Merck KGaA, and US company Mersana Therapeutics, based in Cambridge, Massachusetts, have agreed to collaborate on...
13.06.2014
- Germany's Merck and compatriot biotech firm MorphoSys have agreed to cooperate on discovering and developing therapeutic antibodies against undisclosed immune checkpoints, that is...
07.04.2014
- Merck Serono, the Swiss-based biopharmaceutical division of Germany's Merck KGaA, has signed an exclusive license agreement with U.S. reproductive medicine specialist Auxogyn of...
27.03.2014
- Merck KGaA will propose a 2:1 share split to the annual general meeting held on May 9 in Frankfurt, Germany. The plan calls for splitting one existing no-par value share with a pro...
18.03.2014
- Merck Serono, the biopharmaceutical division of Germany's Merck KGaA, has named Meeta Gulyani as head of strategy and global franchises, effective May 7. She will be based in...
23.12.2013
- Merck Serono, the biopharmaceuticals division of Germany's Merck KGaA, has signed a global license agreement with the Spanish National Research Center (CNIO) in Madrid on cancer...
06.12.2013
- The Consumer Health division of Merck KGaA has made "substantial progress" in raising profitability levels to those of other global over-the-counter drug competitors, the company...
28.11.2013
- German chemicals and pharmaceuticals producer Merck KGaA plans to invest €80 million in a new pharmaceutical plant in the Nantong Economical Technological Development Area of...
